Agonist induction and conformational selection during activation of a G-protein-coupled receptor
- PMID: 12559772
- DOI: 10.1016/S0165-6147(02)00050-0
Agonist induction and conformational selection during activation of a G-protein-coupled receptor
Abstract
Substitutions of Asn111 of the AT(1) angiotensin receptor and mutations of the corresponding amino acids in other G-protein-coupled receptors (GPCRs) cause constitutive receptor activation. Ligand binding and signalling of constitutively active mutant GPCRs are discussed and similarities and differences during the activation of amine and peptide GPCRs are identified. Studies using the AT(1) receptor suggest that conformational selection is not sufficient to explain the mechanism of receptor activation, and that agonist binding to the receptor provides energy to induce activation of the receptor. Because agonist binding also actively facilitates the conformational rearrangements leading to activation of other GPCRs we propose that agonist induction should be considered as a general mechanism of GPCR activation.
Similar articles
-
Use of constitutive G protein-coupled receptor activity for drug discovery.Mol Pharmacol. 2000 Jan;57(1):125-34. Mol Pharmacol. 2000. PMID: 10617687
-
Constitutive activity of G-protein-coupled receptors: cause of disease and common property of wild-type receptors.Naunyn Schmiedebergs Arch Pharmacol. 2002 Nov;366(5):381-416. doi: 10.1007/s00210-002-0588-0. Epub 2002 Sep 6. Naunyn Schmiedebergs Arch Pharmacol. 2002. PMID: 12382069 Review.
-
Functional differences between full and partial agonists: evidence for ligand-specific receptor conformations.J Pharmacol Exp Ther. 2001 Jun;297(3):1218-26. J Pharmacol Exp Ther. 2001. PMID: 11356949
-
Lessons from constitutively active mutants of G protein-coupled receptors.Trends Endocrinol Metab. 2002 Oct;13(8):336-43. doi: 10.1016/s1043-2760(02)00628-8. Trends Endocrinol Metab. 2002. PMID: 12217490 Review.
-
Drug design strategies for targeting G-protein-coupled receptors.Chembiochem. 2002 Oct 4;3(10):928-44. doi: 10.1002/1439-7633(20021004)3:10<928::AID-CBIC928>3.0.CO;2-5. Chembiochem. 2002. PMID: 12362358 Review.
Cited by
-
DNA display selection of peptide ligands for a full-length human G protein-coupled receptor on CHO-K1 cells.PLoS One. 2012;7(1):e30084. doi: 10.1371/journal.pone.0030084. Epub 2012 Jan 10. PLoS One. 2012. PMID: 22253889 Free PMC article.
-
In Silico Study of Allosteric Communication Networks in GPCR Signaling Bias.Int J Mol Sci. 2022 Jul 15;23(14):7809. doi: 10.3390/ijms23147809. Int J Mol Sci. 2022. PMID: 35887157 Free PMC article. Review.
-
Utilization of Biased G Protein-Coupled ReceptorSignaling towards Development of Safer andPersonalized Therapeutics.Molecules. 2019 May 29;24(11):2052. doi: 10.3390/molecules24112052. Molecules. 2019. PMID: 31146474 Free PMC article. Review.
-
A Receptor Model With Binding Affinity, Activation Efficacy, and Signal Amplification Parameters for Complex Fractional Response Versus Occupancy Data.Front Pharmacol. 2019 Jun 11;10:605. doi: 10.3389/fphar.2019.00605. eCollection 2019. Front Pharmacol. 2019. PMID: 31244653 Free PMC article.
-
Common activation mechanism of class A GPCRs.Elife. 2019 Dec 19;8:e50279. doi: 10.7554/eLife.50279. Elife. 2019. PMID: 31855179 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials